Pharmaceutics (May 2024)

Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy

  • Francesca Musumeci,
  • Silvia Schenone

DOI
https://doi.org/10.3390/pharmaceutics16050625
Journal volume & issue
Vol. 16, no. 5
p. 625

Abstract

Read online

Kinases are a family of enzymes comprising over five hundred members, which, when overexpressed or hyperactivated, are implicated in the pathogenesis of numerous hematological and solid cancers [...]

Keywords